21.20.Z - Manufacture of medicines and other pharmaceutical products
10.83.Z - Processing of tea and coffee
10.86.Z - Manufacture of homogenised food preparations and dietetic food
10.89.Z - Manufacture of other food products not elsewhere classified
20.42.Z - Manufacture of perfumes and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical substances
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
77.12.Z - Rental and leasing of other motor vehicle, excluding motorcycles
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 3,7 | 3,1 | -16,5 |
Gross profit (loss) | 1,1 | 3,9 | 3,2 | -18,7 |
EBITDA | 1,6 | 4,5 | 4,4 | -1,7 |
Short time liabilities | 5,5 | 5,4 | 5,8 | 8,9 |
Other operating costs | 0 | 0 | 1,1 | 3138,7 |
Equity capital | 12,4 | 13,8 | 15,9 | 15,5 |
Operating profit (EBIT) | 1,1 | 4 | 3 | -26 |
Assets | 25,2 | 26,8 | 29,2 | 9,1 |
Net profit (loss) | 1 | 3,2 | 2,9 | -9,2 |
Cash | 0 | 0,4 | 0,2 | -57 |
Net income from sale | 15,1 | 23,1 | 21,1 | -8,5 |
Liabilities and provisions for liabilities | 12,8 | 13 | 13,3 | 2,4 |
Working assets | 6,4 | 7,6 | 9,3 | 23,5 |
Other income costs | 0,7 | 0,4 | 1 | 180,7 |
Depreciation | 0,5 | 0,4 | 1,4 | 216,5 |
% | % | % | p.p. | |
Profitability of capital | 8,1 | 23,5 | 18,5 | -5 |
Equity capital to total assets | 49,2 | 51,4 | 54,4 | 3 |
Gross profit margin | 7,4 | 16,8 | 14,9 | -1,9 |
EBITDA Margin | 10,8 | 19,4 | 20,8 | 1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 133 | 85 | 101 | 16 |
Current financial liquidity indicator | 1.1692721843719482 | 1.4103070497512817 | 1.5985199213027954 | 0,2 |
Net dept to EBITDA | 2.864344358444214 | 0.6800447702407837 | 0.4096197187900543 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane